In Other News

• Combined Blood and Genetic Tests Estimate Timing of Alzheimer’s Symptom Onset

• Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions

• Diagnostic Stewardship Guide Targets Testing Overuse and Hospital Cost Pressures

• Hidden Molecular Mechanism Behind HIT Blood-Clotting Disorder Revealed

• Sepsis Diagnostics Market Growth Fueled by Faster Pathogen Detection Needs

• Project Advances Single-Cell Diagnostic Test for Triple-Negative Breast Cancer

• Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions

• Blood Protein Analysis Helps Interpret Uncertain Rare Disease Variants

• International Consensus Guidance Outlines General Population Screening for Early-Stage Type 1 Diabetes

• AI Spatial Analysis of Routine Slides Helps Predict Pancreatic Cancer Recurrence

• Algorithm Uses Blood Biomarkers to Improve Alzheimer’s Trial Screening

• Sysmex and Cytek Collaboration Expands Access to Advanced Clinical Flow Cytometry

• Electrical Fingerprint of Extracellular Vesicles Could Detect Pancreatic Cancer

• Hybrid Computational Imaging Method Improves Digital Pathology Resolution

• 40-Gene Test Validated for High-Risk Squamous Cell Carcinoma

• Common Genetic Marker Predicts Faster Motor Decline in Parkinson’s Disease

• Blood Test Helps Clarify Prostate Cancer Risk After Elevated PSA

• Secure Cloud-Connected qPCR System Enables Remote Infectious Disease Surveillance

• Secure Cloud-Connected qPCR System Enables Remote Infectious Disease Surveillance

• Health Canada Licenses Point-of-Care Hematology Analyzer for Decentralized CBC Testing

• Blood Biomarker May Track Bone Metastases in Medullary Thyroid Cancer

• Project to Develop Maternal Blood Test for Rapid Fetal Oxygen Deprivation Detection

• DPYD Genotyping Assay Supports Safer Fluoropyrimidine Chemotherapy Dosing